Sightsavers: Helping the Nearly Blind to See Again

Sight is wonderful sense that all people should be grateful to have. When a person can see, they have many advantages in life. Sight is arguably the best sense that people have. However, there are many people who are in danger of losing this precious gift. Thankfully, organizations such as Sightsavers are available to help prevent blindness in people all over the world.

 

Sightsavers primarily helps people in developing countries to maintain their sight. They are headquartered in Haywards Heath. This is a town that can be found within the U.K. in England. The charity was started in 1950 by Sir John Wilson. He originally named the organization the British Empire Society for the Blind. Sightsavers has locations within other countries such as the United Arab Emirates, the United States, Norway, Republic of Ireland, Italy and in India.

 

Sightsavers estimates that nearly 80% of all cases involving blindness is preventable. Many people in third-world or developing nations simply do not have the resources to prevent this condition. At least 265 million people have been treated since this organization began in 1950. They also performed over 7 million surgeries to help save peoples site. They have even helped people to regain their eyesight.

There is a huge network of workers at Sightsavers. These workers make it possible for the organization to carry out its work in the third world and developing countries. The organization trains at least 150,000 eye care specialists, primary eye care workers and community volunteers. The community volunteers are extremely important because these individuals go directly to the people to discover if people are suffering from some type of eye condition. They know the remote areas, villages, and people within isolated communities who might need help.

 

In some cases, workers are given a drug to prevent river blindness. They have to carefully control this substance and keep track of the people they treat. Volunteer workers are on the front lines with preventing eye conditions among disenfranchised people. People that are in need of emergency eye treatment can receive it right away in the form of surgery or advance eye care procedures. Sightsavers was placed at the top of the list for charities in 2016 by the charity evaluation organization Give Well. They were recognized for their outstanding work related to blindness prevention and healing.

 
https://sightsaversamerica.org/

Amicus Therapeutics; Passion and Progress in Combating Rare Disease

Amicus Therapeutics is dedicated to staying in the vanguard of modern biotechnology-based therapy. Since 2002, we have continuously pushed forward in the development of cutting-edge treatment to combat a variety of disorders. Our primary focus has been on rare and orphan diseases, with particular attention given to Lysosomal Storage Disorders, Epidermolysis Bullosa, and CDKL5 Deficiency. Utilizing Chaperone-Advanced Replacement Therapy, (CHARTtm), to develop a host of enzyme replacement therapies, Amicus Therapeutics has positioned itself as a leader in the world of small molecule pharmacological chaperones.Lysosomal Storage Disorders, Epidermolysis Bullosa, and CDKL5 Deficiency

 

Through a great deal of hard work, research and development, Amicus Therapeutics has grown and evolved to become a leading innovator in the fight against rare disease (YourBeautyCraze). Widely recognized as holding one of the broadest portfolios of small molecule pharmacological chaperones in the industry, our team strives to support the rare disease community on multiple fronts. Our approach to patient advocacy includes a four-fold approach to healing that includes:

 

Direct and sustained contact with patients and their families, such that two way communication is established for the benefit of all involved. We take the time to learn from our patients and their families and we help them.

 

-Constant research to improve our current therapies, and to create new ones.

 

-Soliciting and utilizing patient input during development and trial processes of out therapies.

 

-Providing up to date resources for all our patients and their families, which help them to navigate the day to day challenges of combating a rare disease.

 

Amicus Therapeutics also actively seeks out opportunities to help educate the broader community about the realities of rare diseases. In doing this, we are able to create a more comprehensive support network to benefit those who are currently combating a rare disease. We believe that healing is something that must happen on multiple levels, which requires efforts above and beyond simply treating the symptoms of an illness.

 

We understand the challenges and the difficulties of coping with a rare disease. There is no single checklist that every patient may follow to recover, or maintain their quality of life. Amicus Therapeutics sees every patient as an individual with unique needs. Our mission, and our passion, is to meet these needs for everyone who must cope with the challenges of a rare disease.

More about Amicus Therapeutics at http://www.gcreport.com/amicus-therapeutics-announces-new-drug-application/